skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

706 Total results for product and free and sample content found

Pink Sheet

Pfizer Skeptical About Value-Based Contracting In Current Environment

By Cathy Kelly 23 Sep 2017

'We have about 18 different projects underway but we've achieved' 


Report: Women Eschew Life Science Companies That Lack Female Leadership

By Mandy Jackson 23 Sep 2017

MassBio and Liftstream partnered on a report about women's, men's and companies' views on gender diversity

Topic Business strategies


Gates Foundation’s $40m Incentivizes Cancer Specialist Immunocore To Develop TB, HIV Drugs

By Lucie Ell 23 Sep 2017

Oxford, UK-based Immunocore, which is developing immunotherapies against cancer

Topic Cancer


APOLLO Success Clears Alnylam For Lift-Off

By Joseph Haas 23 Sep 2017

Phase III APOLLO results finally give the beleagured firm the first late-stage success

Topic Clinical trials

Pink Sheet

Turkey Finds Permanent Solution To Tamoxifen Shortage

By Ahmet Sevindik 23 Sep 2017

The Turkish government plans to fix the country’s tamoxifen drug shortage problem

Datamonitor Healthcare

Depression Infographic

23 Sep 2017

Deep Dive : Depression Drug Development  


Teva Offloads Women's Health Business To Two Firms For $1.38Bn

By Jessica Merrill 21 Sep 2017

The generic drug maker signed two deals to divest its women's health business

Datamonitor Healthcare

Datamonitor Healthcare Analyst Podcast

21 Sep 2017

Zach McLellan, Kevin Shannon, Jack Allen and Ines Mihel discuss current events in the healthcare 

Topic Drug review

Pink Sheet

US FDA's Benefit/Risk Framework Gets High Marks But Could Be Improved

By Sue Sutter 21 Sep 2017

Agency summaries contained in reviews of novel drugs and biologics are useful and informative but difficult to find

Topic Drug approval

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: